Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aflibercept in lung cancer.
Neal JW, Wakelee HA. Neal JW, et al. Expert Opin Biol Ther. 2013 Jan;13(1):115-20. doi: 10.1517/14712598.2013.745847. Epub 2012 Dec 1. Expert Opin Biol Ther. 2013. PMID: 23199019 Review.
Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.
Lu D, Ma Z, Huang D, Zhang J, Li J, Zhi P, Zhang L, Feng Y, Ge X, Zhai J, Jiang M, Zhou X, Simone CB 2nd, Neal JW, Patel SR, Yan X, Hu Y, Wang J. Lu D, et al. Among authors: neal jw. Transl Lung Cancer Res. 2022 Jun;11(6):1119-1131. doi: 10.21037/tlcr-22-403. Transl Lung Cancer Res. 2022. PMID: 35832445 Free PMC article.
Efficacy and safety of first-line anlotinib-based combinations for advanced non-small cell lung cancer: a three-armed prospective study.
Chu T, Zhang W, Zhang B, Zhong R, Zhang X, Gu A, Shi C, Wang H, Xiong L, Lu J, Qian J, Zhang Y, Dong Y, Teng J, Gao Z, Wang W, Shen Y, Nie W, Lim JU, Mehta HJ, Neal JW, Lou Y, Xu J, Zhong H, Han B. Chu T, et al. Among authors: neal jw. Transl Lung Cancer Res. 2022 Jul;11(7):1394-1404. doi: 10.21037/tlcr-22-438. Transl Lung Cancer Res. 2022. PMID: 35958322 Free PMC article.
Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.
Alhusaini S, Lanman TA, Ko RB, Therkelsen KE, Eyben RV, Diehn M, Soltys SG, Pollom EL, Chin A, Vitzthum L, Wakelee HA, Padda SK, Ramchandran K, Loo BW Jr, Neal JW, Nagpal S. Alhusaini S, et al. Among authors: neal jw. Front Oncol. 2023 Mar 24;13:1139940. doi: 10.3389/fonc.2023.1139940. eCollection 2023. Front Oncol. 2023. PMID: 37035171 Free PMC article.
Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.
Nassar AH, Jayakrishnan R, Feng J, Shepherd F, Adib E, Cheung JM, Lin JJ, Liu Y, Lin SH, Parikh K, Sridhar A, Shakya P, Dilling TJ, Kaldas D, Gray JE, Lobachov A, Bar J, Luders H, Grohe C, Gupta S, Leal T, Fitzgerald B, Crowley F, Fujiwara Y, Marron TU, Wilgucki M, Reuss J, Chen L, Sankar K, Aredo JV, Neal JW, Wakelee HA, Thummalapalli R, Yu H, Whitaker R, Velazquez A, Ragavan M, Cortellini A, Kwiatkowski DJ, Naqash AR, Goldberg SB, Kim SY. Nassar AH, et al. Among authors: neal jw. J Thorac Oncol. 2024 Sep 10:S1556-0864(24)02265-2. doi: 10.1016/j.jtho.2024.09.1379. Online ahead of print. J Thorac Oncol. 2024. PMID: 39260522
334 results